Publicaciones en colaboración con investigadores/as de Columbia University Medical Center (3)

2024

  1. Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

    Journal of Clinical Oncology, Vol. 42, Núm. 22, pp. 2702-2712

2022

  1. Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

    Blood, Vol. 140, Núm. 8, pp. 839-850

2020

  1. Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

    Cancer Medicine, Vol. 9, Núm. 22, pp. 8468-8479